-- Days : -- HRS : -- MIN : -- SEC

Register Now →

News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Michael Heile, MD, FAAFP

Articles by Michael Heile, MD, FAAFP

The Evidence for Oral Semaglutide in Type 2 Diabetes From a Managed Care Perspective

ByMichael Heile, MD, FAAFP,Patty Taddei-Allen, PharmD, MBA, BCACP, BCGP

December 15th 2020

Type 2 Diabetes in the US Managed Care Setting: The Burden of Disease and Rationale for an Oral Glucagon-like Peptide-1 Receptor Agonist

ByTanya Dougherty, PharmD, BCPS,Michael Heile, MD, FAAFP

December 14th 2020

Latest Updated Articles

Type 2 Diabetes in the US Managed Care Setting: The Burden of Disease and Rationale for an Oral Glucagon-like Peptide-1 Receptor Agonist
December 14th 2020

Trending on AJMC

As Employers Pull Back on GLP-1s, Andel and Novo Offer a Workaround

Enlicitide LDL-C Lowering Holds Across Risk Levels Up to 2 Years

Tegoprubart Eases Symptom Burden vs Tacrolimus After Kidney Transplant

FDA Approves First Plasmid DNA-Based Immunotherapy for Adults With RRP

HS Comorbidities: Navigating Metabolic, Bowel, Cardiovascular, and Mental Health Risks